S. Louise Phanstiel, Director at MYRIAD GENETICS INC (MYGN), sold 5,000 shares at $44.00 ($220K) on 2015-12-08, disclosed to the SEC on 2015-12-09.
Open-market sale of $220k MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BFLY | BUY | 2025-12-17 | $1.1M | — | Filing → |
| BFLY | SELL | 2024-09-13 | $235K | — | Filing → |
| MYGN | SELL | 2021-08-06 | $3.4M | — | Filing → |